David Adelman
Listed on 6 Form D filings across 5+ issuers
· Director, Executive Officer
Associated issuers
- Vesalius Longevity Labs Inc. CIK 2131865 · British Columbia, Canada
- KC VC 4, LP CIK 2148213 · New York
- KC VC 3, LP CIK 2138101 · New York
- KC VC 7, LP CIK 2139382 · New York
- KC VC 2, LP CIK 2107843 · New York
Filings (6)
-
Vesalius Longevity Labs Inc.D · Nov 18, 2026 · British Columbia, Canada · Pharmaceuticals$13.5MView filing →
-
Vesalius Longevity Labs Inc.D · Nov 3, 2026 · British Columbia, Canada · Pharmaceuticals$30.1MView filing →
-
KC VC 4, LPD · Aug 21, 2026 · New York · Pooled Investment Fund
-
KC VC 3, LPD · Jun 24, 2026 · New York · Pooled Investment Fund
-
KC VC 7, LPD · Jun 24, 2026 · New York · Pooled Investment Fund
-
KC VC 2, LPD · Jan 30, 2026 · New York · Pooled Investment Fund